Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Where Will Editas Medicine Be in 1 Year?

TheMotleyFool

0 0

Where Will Editas Medicine Be in 1 Year?: https://g.foolcdn.com/editorial/images/709891/physician-shaking-patients-hand.jpg

It hasn't been a great year to hold shares of somewhat speculative and unprofitable stocks. Gene-editing specialist Editas Medicine (NASDAQ: EDIT) fits the bill, which is why the company's shares have plunged this year. But things can change quickly in the volatile biotech industry.

Within 12 months, a company can score meaningful clinical or regulatory wins that send its stock price soaring. Could this be what's in store for Editas Medicine in the next year? Let's dig into the company's business to find out.